Liver transplantation without isoniazid prophylaxis for recipients with a history of tuberculosis

Clinical Transplantation

Volumn 21, Issue 2, 2007, Pages 229-234

  Nagai, Shunji ^a   Fujimoto, Yasuhiro ^a   Taira, Kaoru ^b   Egawa, Hiroto ^c   Takada, Yasutsusgu ^b   Kiuchi, Tetsuya ^a   Tanaka, Koichi ^d  

^a NAGOYA UNIVERSITY HOSPITAL   (Japan)

^b Department of Transplantation and Immunology ^*  (Japan)

^c KYOTO UNIVERSITY HOSPITAL   (Japan)

^d INSTITUTE OF BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

Author keywords

Liver transplantation; Postoperative management; Prophylaxis; Reactivation; Tuberculosis

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; ETHAMBUTOL; INTERFERON; ISONIAZID; RIFAMPICIN; STEROID; TACROLIMUS; TUBERCULOSTATIC AGENT;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTERIOSCLEROSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COXITIS; EARLY DIAGNOSIS; FEMALE; GRAFT RECIPIENT; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; LUNG TUBERCULOSIS; MALE; MEDICAL RECORD REVIEW; MYCOBACTERIUM TUBERCULOSIS; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; TOTAL HIP PROSTHESIS; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; COMORBIDITY; FEMALE; HUMANS; ISONIAZID; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; TUBERCULOSIS;

EID: 33947731010     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2006.00630.x     Document Type: Article

References (19)

1. Kiuchi T. Liver transplantation and tuberculosis. Kekkaku 2000: 75: 685.
2. Munoz P, Rodriguez C, Bouza E. Mycobacterium tuberculosis infection in recipients of solid organ transplants. Clin Infect Dis 2005: 40: 581.
3. Verma A, Dhawan A, Wade JJ et al. Mycobacterium tuberculosis infection in pediatric liver transplant recipients. Pediatr Infect Dis J 2000: 19: 625.
4. Singh N, Paterson DL. Mycobacterium tuberculosis infection in solid-organ transplant recipients: Impact and implications for management. Clin Infect Dis 1998: 27: 1266.
5. Aguado JM, Herrero JA, Gavalda J et al. Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Transplant 1997: 63: 1278.
6. Alothman A, Abdulkareem AA, Hemsi BA, Issa S, Sarraj IAI, Masoud F. Isolated hepatic tuberculosis in a transplanted liver. Transplant Infect Dis 2004: 6: 84.
7. Braslavsky G, Jacob N, Maiolo E, Trigo P, Aziz H, Imventarza O. Tuberculosis in liver transplant patients. Transplant Proc 1999: 31: 3063.
8. Graham JC, Kearns AM, Magee JG et al. Tuberculosis transmitted through transplantation. J Infect 2001: 43: 251.
9. Kiuchi T, Inomata Y, Uemoto S et al. A hepatic graft tuberculosis transmitted from a living-related donor. Transplant 1997: 63: 905.
10. Cavusoglu C, Ciek-Saydam C, Karaca Y et al. Mycobacterium tuberculosis infection and laboratory diagnosis in solid-organ transplant recipients. Clin Transplant 2002: 16: 257.
11. Henderson C, Meyers B, Gultekin SH, Liu B, Zhang DY. Intracranial tuberculosis in a liver transplant patient: First case and review of the literature. Am J Transplant 2003: 3: 88.
12. Singh N, Wagener MM, Gayowski T. Safety and efficacy of isoniazid chemoprophylaxis administered during liver transplant candidacy for the prevention of posttransplant tuberculosis. Transplantation 2002: 74: 892.
13. Chaparro SV, Montoya JG, Keeffe EB, Rhee JT, Small PM. Risk of tuberculosis in tuberculin skin test-positive liver transplant patients. Clin Infect Dis 1999: 29: 207.
14. Benito N, Sued O, Moreno A et al. Diagnosis and treatment of latent tuberculosis infection in liver transplant recipients in an endemic area. Transplantation 2002: 74: 1381.
15. Waiser J, Schotshel R, Budde K. Reactivation of tuberculosis after conversion from azathioprine to mycophenolate mofetil 16 yr after renal transplantation. Am J Kidney Dis 2000: 35: E12.
16. Kunimoto D, Warman A, Beckon A, Doering D, Melenka L. Severe hepatotoxicity associated with rifampin-pyrazinamide preventive therapy requiring transplantation in an individual at low risk for hepatotoxicity. Clin Infect Dis 2003: 36: 158.
17. Kopanoff DE, Snider DE, Jr, Caras GJ et al. Isoniazid-related hepatitis: U.S. Public health Service cooperative surveillance study. Am Rev Respir Dis 1978: 117: 991.
18. Farrell FJ, Keeffe EB, Man KM, Imperial JC, Esquivel CO. Treatment of hepatic failure secondary to isoniazid hepatitis with liver transplantation. Dig Dis Sci 1994: 39: 2255.
19. Torre-Cisneros J, Caston JJ, Moreno J et al. Tuberculosis in the transplant candidate: Importance of early diagnosis and treatment. Transplantation 2004: 77: 1376.